华邦生命健康股份有限公司2026年第一次临时股东会决议公告

Group 1 - The company held its first extraordinary general meeting of shareholders in 2026 on January 12, with a total of 397 shareholders (or their proxies) present, representing 553,340,684 shares, which is 27.9476% of the total voting shares [5][6] - The meeting adopted several resolutions, including the approval of credit limits and guarantees for the company and its subsidiaries for the year 2026, with 95.4488% of the votes in favor [6][7] - The meeting also approved the increase of expected related party transactions for 2025 and 2026, with 91.0365% of the votes in favor [7] Group 2 - The company approved a proposal for forward foreign exchange settlement and RMB foreign exchange options for 2026, with 98.5345% of the votes in favor [8] - The meeting passed a resolution to amend the Independent Director Work System, with 95.6379% of the votes in favor [9] - The company also approved the revision of the External Guarantee Management System, with 95.6179% of the votes in favor [10] Group 3 - The company approved the revision of the Related Party Transaction Decision-Making System, with 95.6397% of the votes in favor [11] - The meeting adopted a resolution to amend the Management Measures for the Use of Raised Funds, with 95.6406% of the votes in favor [12] - The company approved the conditions for a non-public issuance of technology innovation exchangeable bonds, with 98.5676% of the votes in favor [14] Group 4 - The company approved the specific proposals related to the issuance of exchangeable bonds, including types, scale, and terms, with significant majorities in favor for each item [15][16][17][18] - The meeting authorized the board of directors to handle all matters related to the non-public issuance of technology innovation exchangeable bonds, with 98.5527% of the votes in favor [34] - The legal opinion from Beijing Times Jiuhua Law Firm confirmed that the meeting's procedures complied with relevant laws and regulations [35]

华邦生命健康股份有限公司2026年第一次临时股东会决议公告 - Reportify